Preparation and Characterization of Febuxostat Nanosuspension as Fast Dissolving Oral Film

Dalbeth N, Choi HK, Joosten LAB, Khanna PP, Matsuo H, Perez-Ruiz F, et al. Gout. Nat Rev Dis Primers. 2019;5(1):69. doi: 10.1038/s41572-019-0115-y. DOI: https://doi.org/10.1038/s41572-019-0115-y

Singh JA, Gaffo A. Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020;50(3S):S11-S16. doi: 10.1016/j.semarthrit.2020.04.008. DOI: https://doi.org/10.1016/j.semarthrit.2020.04.008

Xie H, Hu N, Pan T, Wu JC, Yu M, Wang DC. Effectiveness and safety of different doses of febuxostat compared with allopurinol in treating hyperuricemia: a meta-analysis of randomized controlled trials. BMC Pharmacol Toxicol. 2023;24(1):79. doi: 10.1186/s40360-023-00723-5. DOI: https://doi.org/10.1186/s40360-023-00723-5

Patel J, Jagia M, Bansal AK, Patel S. Characterization and thermodynamic relationship of three polymorphs of a xanthine oxidase inhibitor, febuxostat. J Pharm Sci. 2015;104(11):3722–2730. doi: 10.1002/jps.24570. DOI: https://doi.org/10.1002/jps.24570

Zhang XR, Zhang L. Simultaneous enhancements of solubility and dissolution rate of poorly water-soluble febuxostat via salts. J Mol Struct. 2017;1137:328–334. doi: 10.1016/j.molstruc.2017.02.052. DOI: https://doi.org/10.1016/j.molstruc.2017.02.052

Tang J, Bao J, Shi X, Sheng X, Su W. Preparation, optimization, and in vitro–in vivo evaluation of febuxostat ternary solid dispersion. J Microencapsul. 2018;35(5):454-466. doi: 10.1080/02652048.2018.1526339. DOI: https://doi.org/10.1080/02652048.2018.1526339

Fuhrmann K, Gauthier MA, Leroux JC. Crosslinkable polymers for nanocrystal stabilization. J Control Release. 2010;148(1):e12–13. doi: 10.1016/j.jconrel.2010.07.006. DOI: https://doi.org/10.1016/j.jconrel.2010.07.006

Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004;3(9):785–796. doi: 10.1038/nrd1494. DOI: https://doi.org/10.1038/nrd1494

Müller R, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy. Adv Drug Deliv Rev. 2001;47(1):3–19. doi: 10.1016/S0169-409X(00)00118-6. DOI: https://doi.org/10.1016/S0169-409X(00)00118-6

Rajab NA, Jassim ZE, Hameed AM. Preparation and characterization of lacidipine as an oral fast-dissolving film. Drug Invent Today. 2018;10(1):321–326.

Kathpalia H, Gupte A. An introduction to fast dissolving oral thin film drug delivery systems: a review. Curr Drug Deliv. 2013;10(6):667-684. doi: 10.2174/156720181006131125150249. DOI: https://doi.org/10.2174/156720181006131125150249

Pandit Shubham R, Shendge Raosaheb S, PulateAniket J, Patil Suresh D, PathareVaishnavi BPAS. Review on: Mouth dissolving film. Int J Pharm Res Appl. 2021;6(3):370–378. doi: 10.35629/7781-0603370378.

Gavaskar B, Kumar SV, Sharan G, Madhusudan Rao Y. Overview on fast dissolving films. Int J Pharm Pharm Sci. 2010;2(Suppl. 3):29–33.

Patel AR, Prajapati DS, Raval JA. Fast dissolving films (FDFs) as a newer venture in fast dissolving dosage forms. Int J Drug Dev Res. 2010;2(2):232–246.

Lu S, Yu P, He JH, Shuang ZS, Xia YL, Zhang WL, et al. Enhanced dissolution and oral bioavailability of lurasidone hydrochloride nanosuspensions prepared by antisolvent precipitation–ultrasonication method. RSC Adv. 2016;6(54):49052–49059 .doi: 10.1039/C6RA08392G. DOI: https://doi.org/10.1039/C6RA08392G

Kadhim ZJ, Rajab NA. Formulation and characterization of glibenclamide nanoparticles as an oral film. Int J Drug Deliv Technol. 2022;12(1):387–394. doi: 10.25258/ijddt.12.1.70.

Mathew A, Jacob S, Shyma MS. Nanosuspension loaded oral films: A breakthrough approach. J Pharm Sci Res. 2020;12(8):1012–1017.

Kumar S, Doddayya H. Fabrication and evaluation of mouth-dissolving films of domperidone. Int J Curr Pharm Res. 2023;15(2):36–43. doi: 10.22159/ijcpr.2023v15i2.2088. DOI: https://doi.org/10.22159/ijcpr.2023v15i2.2088

Bharti K, Mittal P, Mishra B. Formulation and characterization of fast dissolving oral films containing buspirone hydrochloride nanoparticles using design of experiment. J Drug Deliv Sci Technol. 2019;49:420–432. doi: 10.1016/j.jddst.2018.12.013. DOI: https://doi.org/10.1016/j.jddst.2018.12.013

Saxena S, Patel A, Kumar Jain SK. Formulation and evaluation of mouth dissolving film of antihypertensive agent Formulation and evaluation of mouth dissolving film of antihypertensive agent. World J Adv Res Rev. 2022;16(2):1107–1116. doi:10.30574/wjarr.2022.16.2.1251. DOI: https://doi.org/10.30574/wjarr.2022.16.2.1251

Bala R, Khanna S, Pawar P, Arora S. Orally dissolving strips: A new approach to oral drug delivery system. Int J Pharm Investig. 2013;3(2):67. doi: 10.4103%2F2230-973X.114897. DOI: https://doi.org/10.4103/2230-973X.114897

Sajayan K, Swathy KK, Sarath Chandran C, Jafna MC, Nair RS, Sourav K, et al. Development and evaluation of fast dissolving oral films of mefenamic acid for the management of fever. Indian J Pharm Educ Res. 2023;57(1):s41–51. doi: 10.5530/ijper.57.1s.6. DOI: https://doi.org/10.5530/ijper.57.1s.6

Jassim ZE, Mohammed MF, Sadeq ZA. Formulation and evaluation of fast dissolving film of lornoxicam. Asian J Pharm Clin Res. 2018;11(9):217. doi: 10.22159/ajpcr.2018.v11i9.27098. DOI: https://doi.org/10.22159/ajpcr.2018.v11i9.27098

Shamma R, Elkasabgy N. Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use. Drug Deliv. 2016;23(2):489–499. doi:10.3109/10717544.2014.921944. DOI: https://doi.org/10.3109/10717544.2014.921944

Zhang L, Aloia M, Pielecha-Safira B, Lin H, Rajai PM, et al. Impact of superdisintegrants and film thickness on disintegration time of strip films loaded with poorly water-soluble drug microparticles. J Pharm Sci. 2018;107(8):2107-2118. doi: 10.1016/j.xphs.2018.04.006. DOI: https://doi.org/10.1016/j.xphs.2018.04.006

Ahuja BK, Jena SK, Paidi SK, Bagri S, Suresh S. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension. Int J Pharm. 2015;478(2):540–552. doi: 10.1016/j.ijpharm.2014.12.003. DOI: https://doi.org/10.1016/j.ijpharm.2014.12.003

Xu T, Li H, Xia Y, Ding S, Yang Q, Yang G. Three-Dimensional-Printed Oral Films Based on LCD: Influence Factors of the Film Printability and Received Qualities. Pharmaceutics. 2023;15(3):758. doi: 10.3390/pharmaceutics15030758. DOI: https://doi.org/10.3390/pharmaceutics15030758

Jabir SA, Sulaiman HT. Preparation and characterization of lafutidine as immediate release oral strip using different type of water-soluble polymer. Int J Appl Pharm. 2018;10(5):249–260. doi: 10.22159/ijap.2018v10i5.28292. DOI: https://doi.org/10.22159/ijap.2018v10i5.28292

Kini A, Patel SB. Phase behavior, intermolecular interaction, and solid-state characterization of amorphous solid dispersion of Febuxostat. Pharm Dev Technol. 2017;22(1):45–57. doi: 10.3109/10837450.2016.1138130. DOI: https://doi.org/10.3109/10837450.2016.1138130

Mansur HS, Sadahira CM, Souza AN, Mansur AAP. FTIR spectroscopy characterization of poly (vinyl alcohol) hydrogel with different hydrolysis degrees and chemically crosslinked with glutaraldehyde. Mater Sci Eng C. 2008; 28(4):539–548. doi: 10.1016/j.msec.2007.10.088. DOI: https://doi.org/10.1016/j.msec.2007.10.088

Pawar PG, Darekar A, Saudagar RB. Formulation, Development, and Evaluation of Febuxostat Loaded Microsponges. Int J Res Advent Technol. 2019;7(5):523–533. doi: 10.32622/ijrat.752019326. DOI: https://doi.org/10.32622/ijrat.752019326

Abd-Alhammid SN, Saleeh HH. Formulation and evaluation of flurbiprofen oral film. Iraqi J Pharm Sci. 2014; 23(1):53–59. doi: 10.31351/vol23iss1pp53-59. DOI: https://doi.org/10.31351/vol23iss1pp53-59

Tamer MA, Abd-Al Hammid SN, Ahmed B. Formulation and in vitro evaluation of bromocriptine mesylate as fast dissolving oral film. Int J Appl Pharm. 2018;10(1):7-20. doi: 10.22159/ijap.2018v10i1.22615. DOI: https://doi.org/10.22159/ijap.2018v10i1.22615

Aulton ME, Taylor K, eds. Aulton’s Pharmaceutics: The Design and Manufacture of Medicines, (5th ed.), Edinburgh: Churchill Livingstone /Elsevier; 2018. 36.

Nagy ZK, Balogh A, Vajna B, Farkas A, Patyi G, Kramarics Á, et al. Comparison of electrospun and extruded Soluplus®-based solid dosage forms of improved dissolution. J Pharm Sci. 2012;101(1):322–332. doi: 10.1002/jps.22731. DOI: https://doi.org/10.1002/jps.22731

Sundari PT, Lad K. Physico-chemical characterization and in vitro evaluation of biopharmaceutics classification system class II drug febuxostat. Asian J Pharm. 2016;10(2):S162-S169. doi: 10.22377/ajp.v10i2.640.

Kaur M, Mittal A, Gulati M, Sharma D, Kumar R. Formulation and in vitro evaluation of fast dissolving tablets of febuxostat using co-processed excipients. Recent Pat Drug Deliv Formul. 2020;14(1):48-62. doi: 10.2174/1872211314666191224121044. DOI: https://doi.org/10.2174/1872211314666191224121044

Hadke A, Pethe A, Vaidya S, Dewani S. Formulation development and characterization of lyophilized febuxostat nanosuspension. Int J Appl Pharm. 2022;14(6):91-99. doi: 10.22159/ijap.2022v14i6.45614. DOI: https://doi.org/10.22159/ijap.2022v14i6.45614